Kiora Pharmaceuticals logo

Kiora Pharmaceuticals

KPRX | NASDAQ
Chart Builder DCF Calculator
$0.98
-$0.25 (-20.33%)
At close: Nov 16, 2026, 4:00 PM ET
$1.00
+$0.02 (+2.04%)
After-hours: Nov 16, 2026, 7:05 PM ET
-20.33%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25
+7.0 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #932/1021 (Top 91%)

Key Statistics

Market Data

Market Cap $6.17M
1D Range
0.93 1.25
52W Range
0.93 2.86

Valuation (TTM)

PE -0.35
PB 0.40
EV/EBITDA 0.87

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across ...

Sector Healthcare
Industry Biotechnology
Employees 13
IPO Date Feb 13, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.28
Beat +26.32%
REV
$1M
Beat 0.00%
Next Earnings
Mar 30, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.